常规超声联合超声造影评估乳腺癌新辅助化疗后腋窝淋巴结状态
研究纳入74例接受新辅助化疗的乳腺癌患者,在化疗前后行常规超声和超声造影检查,记录淋巴结髓质边界、皮质、淋巴门、纵横比及超声造影方式和模式。化疗6~8周期后,46例(71.9%)腋窝淋巴结阴性,18例(28.1%)非pCR。淋巴结髓质、纵横比及超声造影方式与pCR独立相关,联合预测模型AUC为0.882(95%CI:0.608-0.958),准确率78.1%(p<0.01)。结论认为常规超声联合超声造影可准确预测新辅助化疗后腋窝淋巴结状态。
要点
- 新辅助化疗后评估腋窝淋巴结pCR时,需重点观察淋巴结髓质、纵横比及超声造影方式。
- 常规超声联合超声造影预测pCR的AUC为0.882,准确率78.1%。
- 超声造影方式与pCR独立相关,可作为常规超声的补充评估指标。
关键影像表现/征象
- 常规超声记录淋巴结髓质边界、皮质、淋巴门及纵横比四项特征。
- 超声造影分析造影方式和造影模式两项特征。
- 淋巴结髓质、纵横比及超声造影方式与新辅助化疗后腋窝淋巴结pCR独立相关。
诊断标准与关键数值
- 联合淋巴结髓质、纵横比及超声造影方式三项特征的预测模型AUC为0.882(95%CI:0.608-0.958)。
- 该模型预测腋窝淋巴结状态的准确率为78.1%(p<0.01)。
临床应用与阅片要点
- 新辅助化疗后腋窝淋巴结评估应常规观察髓质、纵横比,并建议补充超声造影观察造影方式。
- 联合三项影像特征可提高预测pCR的准确性,辅助临床决策。
局限性
- 单中心研究,样本量74例,结论需多中心验证。
- 仅评估常规超声联合超声造影,未与其他影像方法比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Axillary lymph node status assessment has always been an important issue in clinical treatment of breast cancer. However, there has been no effective method to accurately predict the pathological complete response (pCR) of axillary lymph node after neoadjuvant chemotherapy (NAC). The objective of our study was to investigate whether conventional ultrasonography combined with contrast-enhanced ultrasonography (CEUS) can be used to evaluate axillary lymph node status of breast cancer patients after NAC.
METHODS: A total of 74 patients who underwent NAC were recruited for the present study. Prior to and after NAC, examinations of conventional ultrasonography and CEUS were performed. After evaluating the images of conventional ultrasonography, four characteristics were recorded: lymph node medulla boundary, cortex of lymph node, lymph node hilus, and lymph node aspect ratio. Two additional imaging characteristics of CEUS were analyzed: CEUS way and CEUS pattern. Receiver operating characteristiccurve analysis was applied to evaluate their diagnostic performance.
RESULTS: After 6~8 cycles of NAC, 46 (71.9%) patients had negative axillary lymph node, and 18 (28.1%) patients turned out non-pCR. According to statistical analysis, lymph node medulla, lymph node aspect ratio and CEUS way were independently associated with pCR of axillary lymph node after NAC. The area under the curve of the prediction model with three imaging characteristics was 0.882 (95% confidence interval: 0.608-0.958), and the accuracy to predict the patients' lymph node status was 78.1% (p < 0.01).
CONCLUSIONS: Conventional ultrasonography combined with CEUS technology can accurately predict axillary lymph nodes status of breast cancer patients after NAC.
ADVANCES IN KNOWLEDGE: The usefulness of CEUS technology in predicting pCR after neoadjuvant chemotherapy is highlighted.
引用
- Han X, Jin S, Yang H, et al. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients. Br J Radiol. 2021. PMID: 34415197. doi:10.1259/bjr.20210520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。